<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药春秋 | wechat-feeds</title><link>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</link><description>医药行业一致性评价工作在如火如荼的进行中，作为行业的一份子，愿本愚公之念，出蝼蚁 之力，献寸光之策。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 25 Apr 2021 23:23:19 +0800</pubDate><image><url>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</url><title>药春秋 | wechat-feeds</title><link>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>「吗丁啉」优势不再，国产仿制大有接管市场之意！</title><link>https://mp.weixin.qq.com/s/jKdzMGudNgLP-ihKbykYvQ</link><description></description><content:encoded><![CDATA[「吗丁啉」优势不再，国产仿制大有接管市场之意！]]></content:encoded><pubDate>Sun, 25 Apr 2021 21:41:51 +0800</pubDate></item><item><title>美托洛尔：两种酸根，相隔大半个市场</title><link>https://mp.weixin.qq.com/s/fqB8NJJ9Z5UJKww8MnPTSA</link><description></description><content:encoded><![CDATA[美托洛尔：两种酸根，相隔大半个市场]]></content:encoded><pubDate>Sun, 25 Apr 2021 21:41:51 +0800</pubDate></item><item><title>422个药品，拟调入（出）短缺药目录</title><link>https://mp.weixin.qq.com/s/9mA1rArIli3nwU964uU2og</link><description></description><content:encoded><![CDATA[422个药品，拟调入（出）短缺药目录]]></content:encoded><pubDate>Sun, 25 Apr 2021 21:41:51 +0800</pubDate></item><item><title>原料药垄断再掀风波，谁懂制剂企业背后的辛酸点滴？</title><link>https://mp.weixin.qq.com/s/usop2swNjaKrBZXmlXgCcg</link><description></description><content:encoded><![CDATA[原料药垄断再掀风波，谁懂制剂企业背后的辛酸点滴？]]></content:encoded><pubDate>Sun, 25 Apr 2021 21:41:51 +0800</pubDate></item><item><title>“开挂”的印度制药，却是凭实力仿的药！</title><link>https://mp.weixin.qq.com/s/bnBmsyQeOfZZYwO_-E8awQ</link><description></description><content:encoded><![CDATA[“开挂”的印度制药，却是凭实力仿的药！]]></content:encoded><pubDate>Sat, 24 Apr 2021 21:36:56 +0800</pubDate></item><item><title>最新一致性评价目录，注射剂大获全胜！</title><link>https://mp.weixin.qq.com/s/_PE66HO47kPcTu48h7szQg</link><description></description><content:encoded><![CDATA[最新一致性评价目录，注射剂大获全胜！]]></content:encoded><pubDate>Fri, 23 Apr 2021 21:45:39 +0800</pubDate></item><item><title>一大批品种动态调价，最高降幅63.5%！</title><link>https://mp.weixin.qq.com/s/NH77EVRvThWxG6pnLh5hsw</link><description></description><content:encoded><![CDATA[一大批品种动态调价，最高降幅63.5%！]]></content:encoded><pubDate>Fri, 23 Apr 2021 21:45:39 +0800</pubDate></item><item><title>165个药品取消挂网</title><link>https://mp.weixin.qq.com/s/ckokw55PSNEzsLsk5k0Dzw</link><description></description><content:encoded><![CDATA[165个药品取消挂网]]></content:encoded><pubDate>Fri, 23 Apr 2021 21:45:39 +0800</pubDate></item><item><title>【FDA】ICH-Q8,Q9,Q10注册技术要点</title><link>https://mp.weixin.qq.com/s/_f4KgmamkiQHXxuUM8y_yg</link><description></description><content:encoded><![CDATA[【FDA】ICH-Q8,Q9,Q10注册技术要点]]></content:encoded><pubDate>Fri, 23 Apr 2021 21:45:39 +0800</pubDate></item><item><title>微球技术哪家强？且看四大领头玩家强势领跑</title><link>https://mp.weixin.qq.com/s/BRaQZmAmbNEn61SSACNAVw</link><description></description><content:encoded><![CDATA[微球技术哪家强？且看四大领头玩家强势领跑]]></content:encoded><pubDate>Thu, 22 Apr 2021 21:41:57 +0800</pubDate></item><item><title>抗凝新力军 - 艾多沙班，踏上“医保”的巨轮乘风破浪吧！</title><link>https://mp.weixin.qq.com/s/9xy7nhcFg0Cjbx40lLukPw</link><description></description><content:encoded><![CDATA[抗凝新力军 - 艾多沙班，踏上“医保”的巨轮乘风破浪吧！]]></content:encoded><pubDate>Thu, 22 Apr 2021 21:41:57 +0800</pubDate></item><item><title>定了！医保、采购金额前80%等品种，通通纳入集采！</title><link>https://mp.weixin.qq.com/s/1_GTy_NOSJI7JgG0nxdn1g</link><description></description><content:encoded><![CDATA[定了！医保、采购金额前80%等品种，通通纳入集采！]]></content:encoded><pubDate>Thu, 22 Apr 2021 21:41:57 +0800</pubDate></item><item><title>NMPA成绩单：一致性评价申请881件，仿制批件722个...</title><link>https://mp.weixin.qq.com/s/QGOzYdGthMzfCaoELLqYBw</link><description></description><content:encoded><![CDATA[NMPA成绩单：一致性评价申请881件，仿制批件722个...]]></content:encoded><pubDate>Thu, 22 Apr 2021 21:41:57 +0800</pubDate></item><item><title>（2021.4.21）最新过评名单；7亿抗菌注射剂，齐鲁先行拿下！</title><link>https://mp.weixin.qq.com/s/H2q9dFwnBmeiUky80dFeGw</link><description></description><content:encoded><![CDATA[（2021.4.21）最新过评名单；7亿抗菌注射剂，齐鲁先行拿下！]]></content:encoded><pubDate>Wed, 21 Apr 2021 21:40:22 +0800</pubDate></item><item><title>三层次梯度降价，国采非中选药机会来了！</title><link>https://mp.weixin.qq.com/s/8V42k1kHs764EvIIM09OLQ</link><description></description><content:encoded><![CDATA[三层次梯度降价，国采非中选药机会来了！]]></content:encoded><pubDate>Wed, 21 Apr 2021 21:40:22 +0800</pubDate></item><item><title>17个短缺药新增挂网</title><link>https://mp.weixin.qq.com/s/BHdM5iKh-1FfWqKgiZH_8A</link><description></description><content:encoded><![CDATA[17个短缺药新增挂网]]></content:encoded><pubDate>Wed, 21 Apr 2021 21:40:22 +0800</pubDate></item><item><title>小科普丨快速了解药品从研发到上市的全过程</title><link>https://mp.weixin.qq.com/s/OHBTpORFdIyLFrxFxnzGZw</link><description></description><content:encoded><![CDATA[小科普丨快速了解药品从研发到上市的全过程]]></content:encoded><pubDate>Wed, 21 Apr 2021 21:40:22 +0800</pubDate></item><item><title>集采后时代 - 他汀类药物还剩多少余量？</title><link>https://mp.weixin.qq.com/s/3Fhg-rE72Ztm1MJcgUCv5w</link><description></description><content:encoded><![CDATA[集采后时代 - 他汀类药物还剩多少余量？]]></content:encoded><pubDate>Tue, 20 Apr 2021 21:38:18 +0800</pubDate></item><item><title>知名重磅注射液，再现降价潮！</title><link>https://mp.weixin.qq.com/s/hj5uSDl0vmGJvEf06BlA5g</link><description></description><content:encoded><![CDATA[知名重磅注射液，再现降价潮！]]></content:encoded><pubDate>Tue, 20 Apr 2021 21:38:18 +0800</pubDate></item><item><title>国采非中选药价格调整，大批原研产品在列...</title><link>https://mp.weixin.qq.com/s/iMTh08VbJwT0Jk9NHEFghQ</link><description></description><content:encoded><![CDATA[国采非中选药价格调整，大批原研产品在列...]]></content:encoded><pubDate>Tue, 20 Apr 2021 21:38:18 +0800</pubDate></item></channel></rss>